Biomark Diagnostics (PK) Stock Quote BMKDF - Stock Price, News, Charts, Message Board, Trades

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
USA
USOTC
Biomark Diagnostics Inc (PK) (BMKDF) Quote

Biomark Diagnostics Inc (PK) (BMKDF)

0.23

0.00

(0.00%)

Closed April 29 4:00PM

Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Current Price

0.23

Bid

0.20

Ask

0.22

Volume

-

0.00 Day's Range 0.00

0.143 52 Week Range 0.253062

Market Cap

Previous Close

0.23

Open

-

Last Trade

Last Trade Time

Financial Volume

-

VWAP

-

Average Volume (3m)

15,699

Shares Outstanding

90,886,229

Dividend Yield

-

PE Ratio

-11.33

Earnings Per Share (EPS)

-0.02

Revenue

153k

Net Profit

-1.84M

Sector

Medical Laboratories

Industry

Medical Laboratories

Website

www.biomarkdiagnostics.com

Headquarters

Richmond, British Columbia, Can

Founded

1970

Biomark Diagnostics Inc (PK) is listed in the Medical Laboratories sector of the OTCMarkets with ticker BMKDF. The last closing price for Biomark Diagnostics (PK) was $0.23. Over the last year, Biomark Diagnostics (PK) shares have traded in a share price range of $ 0.143 to $ 0.253062.

Biomark Diagnostics (PK) currently has 90,886,229 shares outstanding. The market capitalization of Biomark Diagnostics (PK) is $20.90 million. Biomark Diagnostics (PK) has a price to earnings ratio (PE ratio) of -11.33.

No news to show yet.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.0137	6.33379565418	0.2163	0.23	0.205	14879	0.20901887	CS
4	0.0184	8.69565217391	0.2116	0.23	0.18	11103	0.20746878	CS
12	0.03	15	0.2	0.2303	0.18	15699	0.21199705	CS
26	0.03752	19.4929343308	0.19248	0.2303	0.148	13399	0.20470133	CS
52	0.067	41.1042944785	0.163	0.253062	0.143	13928	0.19359692	CS
156	-0.22156	-49.0654619541	0.45156	0.50548	0.118	13570	0.20996374	CS
260	0.1767	331.519699812	0.0533	0.5083	0.0533	16016	0.23603347	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
AAGRAfrican Agriculture Holdings Inc	$ 0.00 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	$ 0.00 (0.00%)	0
AADIAadi Bioscience Inc	$ 0.00 (0.00%)	0
AACIArmada Acquisition Corporation I	$ 0.00 (0.00%)	0
AACGATA Creativity Global	$ 0.00 (0.00%)	0
AAGRAfrican Agriculture Holdings Inc	$ 0.00 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	$ 0.00 (0.00%)	0
AADIAadi Bioscience Inc	$ 0.00 (0.00%)	0
AACIArmada Acquisition Corporation I	$ 0.00 (0.00%)	0
AACGATA Creativity Global	$ 0.00 (0.00%)	0
AAGRAfrican Agriculture Holdings Inc	$ 0.00 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	$ 0.00 (0.00%)	0
AADIAadi Bioscience Inc	$ 0.00 (0.00%)	0
AACIArmada Acquisition Corporation I	$ 0.00 (0.00%)	0
AACGATA Creativity Global	$ 0.00 (0.00%)	0

MERCURIAL

MERCURIAL 4 years ago

I hear you. Loading :)

MADDSTACKER

MADDSTACKER 4 years ago

Covid and lung cancer screening this going to dollars imho ...

MADDSTACKER

MADDSTACKER 4 years ago

I’m so alone .. can anyone hear me .. bawhahahaha

MADDSTACKER

MADDSTACKER 4 years ago

Covid test kits , in talks with government ,, 2 weeks expect a roll out ....

STOCKPICKER4LIFE

STOCKPICKER4LIFE 7 years ago

ronpopeil

ronpopeil 7 years ago

Does anyone follow this company anymore?

Bing420

Bing420 8 years ago

Soooo...any reason for the tanking in the last day?

MichaelVest

MichaelVest 8 years ago

BioMark raw data collection complete on 200 patient trial. Data will be reviewed then compiled into a report. Trial met both Health Canada and U.S. FDA standards.

Complete article below:

Data Collection

MichaelVest

MichaelVest 8 years ago

Expect commercializing of BioMark's early detection red alert technology. Looking like 2016 will be a big year for BioMark!!!

MichaelVest

MichaelVest 8 years ago

BioMark receives approval from Health Canada and the Ethics Review Board for their lung cancer protocol, and will now start pilot study at CancerCare Manitoba in April.

Full article here: Lung Cancer Protocol

MichaelVest

MichaelVest 8 years ago

Great Video BioMark Cancer Survivorship Program

Cancer Survivorship Program

MichaelVest

MichaelVest 8 years ago

A good article regarding BioMark

A Good Choice For MMJ and Biotech Market Opportunity

MichaelVest

MichaelVest 8 years ago

BioMark Announces Progress

[url][/url][tag]Progress with Assayhttp://www.biomarkdiagnostics.com/investor-relations/investment-highlights/news-releases/[/tag]

MichaelVest

MichaelVest 9 years ago

Quest for Game Changing Lung Cancer Diagnostic Assay Video

MichaelVest

MichaelVest 9 years ago

BioMark expects to begin study of its' assay in 4th quarter of 2015

Begin assay study in 4th quarter

MichaelVest

MichaelVest 9 years ago

BioMark receives clearance from Health Canada to commence clinical trial of their assay.

Health Canada clearance

MichaelVest

MichaelVest 9 years ago

Interim financial report June 2015

Fin. report

MichaelVest

MichaelVest 9 years ago

Dr. Thomas Malcolm to head U.S. operations. Brings experience to U.S. strategy.

Ph.D in molecular biology and biochemistry, and a post doctoral fellow for both Mount Sinai School of Medicine and Memorial Sloan Kettering Cancer Center.

MichaelVest

MichaelVest 9 years ago

BioMark lays out plan for U.S.

Going to be based in Maryland, appointed head of U.S. operations, planning on gaining approval from Health Canada in 2016, then FDA approval to follow.

U.S. Strategy

MichaelVest

MichaelVest 9 years ago

BioMark is four weeks out with data on their assay cancer test. Look to be meeting all requirements for FDA.

Press release here

MichaelVest

MichaelVest 9 years ago

Two patent applications for BioMark below:

Monoclonal Antibody

and

Method for Assaying

MichaelVest

MichaelVest 9 years ago

Company currently holds patent for their tech. Patent number 6811967 Link below for full patent information:

Full patent info

MichaelVest

MichaelVest 9 years ago

From Nov. 2014 but good information on what the company is trying to do.

BioMark Diagnostics Info

GoBison

GoBison 9 years ago

Anyone trading this yet?

jupp

jupp 9 years ago

BioMark Announces Grant Funded Partnership With TMIC

www.fscwire.com/newsrelease/biomark-announces-grant-funded-partnership-tmic

BioMark Brings New Life to Cancer Detection Technology

www.biomarkdiagnostics.com/biomark-brings-new-life-to-cancer-detection-technology/

BioMark Announces Private Placement

www.fscwire.com/newsrelease/biomark-announces-private-placement

Biomark Diagnostics (PK)

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions